Key words: bioelectrical impedance; blood pressure; congestive heart failure; Finapres; haemodialysis; Background. In the presence of elevated cardiac filling pressures, the decline of blood pressure (BP) during Valsalva manoeuvre the straining phase of a Valsalva manoeuvre is blunted or absent. We compared the use of non-invasively measured BP response to a Valsalva manoeuvre with
measured BP response to a Valsalva manoeuvre with Introduction clinical assessment and bioimpedance measurements to identify haemodialysis patients at risk of acute congestOverestimation of dry weight for patients on maintenive heart failure (CHF ).
ance haemodialysis can lead to central fluid overload Methods. Continuous BP response (Finapres) to a with the subsequent risk of hypertension and acute Valsalva manoeuvre, clinical assessment by nephrologcongestive heart failure (CHF ). Particularly in patients ists, and bioimpedance estimations of extracellular with pre-existing left ventricular dysfunction, fluid fluid volume were determined before and after haemooverload can cause an increase in left ventricular enddialysis, once every week during a 5-week period.
diastolic pressure, leading to acute pulmonary edema Acute CHF was defined according to preset clinical [1] . However, identification of patients at risk may be and radiological criteria.
difficult, since quantification of fluid retention by Results. Participants (age 60±19 years, six females, means of physical examination is difficult, and results nine males) had an average predialysis weight of correlate poorly with hemodynamic measures of car-66.8±11.8 kg. Patients were dialysed for 3.8±0.8 h diac function [2, 3] . Determination of left ventricular with a mean ultrafiltration of 2.4±1.1 litres. Valsalva end-diastolic pressure or pulmonary capillary wedge systolic BP ratios (phase 2 to 1) decreased signifipressure (PCWP), measured invasively by means of cantly during dialysis from 0.81±0.11 to 0.73±0.10 right heart catheterization, is normally used to establish (P<0.05). Five patients experienced an episode of both the diagnosis of CHF and the degree of left acute CHF. The Valsalva BP ratios for these patients ventricular dysfunction [4] . Elevation of PCWP is before and after dialysis (0.89±0.05 and 0.78±0.05 highly predictive of pulmonary congestion. respectively) were higher than for the remaining ten In earlier studies it was noted that measurement of patients (0.77±0.10 and 0.70±0.11, respectively) the blood pressure (BP) response to the Valsalva (P<0.05). A cutoff Valsalva BP ratio of 0.82 resulted manoeuvre, i.e. sustained straining against an airway in positive and negative predictive values for CHF of resistance, might be useful for estimating left ventricu-62 and 100% respectively. No differences in clinical lar filling pressures and determining the presence of assessment or bioimpedance parameters were found, CHF [5-9]. However, clinical application of this test with the exception of postdialysis diastolic BP and was limited because of the need for intra-arterial predialysis ankle oedema. After treatment of CHF, measurement of the BP to quantify beat-to-beat Valsalva BP ratios decreased significantly without changes during a Valsalva manoeuvre. Non-invasive, changes in the other hydration parameters.
continuous, and reliable measurement of the BP Conclusions. Non-invasive assessment of the BP response to Valsalva manoeuvre by means of a plethysresponse to a Valsalva manoeuvre appears to be a mographic device such as Finapres recently became potential tool for identifying patients at risk of acute possible [10, 11] . Since then, non-invasive measurement CHF during maintenance haemodialysis.
of the BP response to Valsalva manoeuvre has been validated as a method for predicting PCWP [12] [13] [14] .
pulmonary congestion which is not demonstrated by the usual clinical parameters. The objective of our study was to evaluate the use of the Valsalva manoeuvre to identify haemodialysis patients at risk of acute CHF. We compared this procedure with the results of clinical assessment as well as estimation of extracellular fluid volumes by means of bioimpedance measurements. We further explored the effects of treatment of acute CHF on the parameters mentioned above.
Subjects and methods
Fifteen consecutive clinically stable patients on maintenance haemodialysis participated in the study. Patients with continuous cardiac arrhythmias such as atrial fibrillation were excluded, since a reliable beat-to-beat analysis of the Valsalva BP response could not be performed. The study was approved by the ethical committee of the participating hospital, and all patients gave their informed consent. During a 2-week initiation period, patients were familiarized with the protocol. Subsequently, measurements were serum haemoglobin concentrations were used to estimate the decrease in blood volume during haemodialysis, assuming that red-cell mass remained unchanged during dialysis. minimum systolic BP values always occurred within 10 s of Rigorous clinical assessment, including an extensive his-achievement of 35 mmHg blowing pressure. tory, was performed by one of two experienced nephrologists Extracellular fluid volume (EFV ) was computed from (RG or MS ). One point was assigned to each finding of whole body conductivity measurements before and after dyspnoea, pulmonary rales, elevated jugular venous pressure, dialysis. Electrodes were attached to the patient's right hand or oedema. The sum score over 5 weeks was calculated for and right foot and left in place during dialysis. Measurements every item and every patient. Before and after haemodialysis, and calculations were performed according to the total body weight was measured to the nearest 0.1 kg using manufacturer's specifications (Bodycomp II, BIA buS, an electronic scale (SECA, Germany), and BP was measured Akern, Florence, Italy). Body surface area was estimated with a standard sphygmomanometer. Acute CHF was defined from nomograms of body-weight and height. as the presence of at least four of the following: acute Data are presented as means±1 SD. Correlations between dyspnoea at rest, elevated jugular venous pressure, blood measurement values were determined using Spearman rank pressure over 180/110 mmHg, pulmonary rales, and cardi-correlation coefficients. Intradialytic changes in hydration omegaly or pulmonary congestion on the chest X-ray. The parameters were evaluated by means of the Wilcoxon signed nephrologists were not aware of the results of Valsalva's BP rank test. The event group and the non-event group were nor the bioimpedance measurements until the end of study; compared by means of the Wilcoxon rank sum test. A P Valsalva and impedance measurements did not play any role value of less than 0.05 was considered significant. in treatment decisions.
Within 5 min after start and before end of haemodialysis, patients performed a Valsalva manoeuvre. This was done in Results a semi-supine position (30°tilt), by blowing forcefully for 10 to 12 s into a blowpipe connected to a pressure transducer.
Patient characteristics are shown in Table 1 . The fifteen They were assisted in the maintenance of a straining pressure participants had a mean age of 60±19 years and an of 35-40 mmHg by observing an on-line monitor display. A tiny air leak in the mouthpiece ensured that the airway average predialysis weight of 66.8±11.8 kg. Six pressure was produced from the thoracic cavity and not the patients were female. Eleven patients had a medical pharynx. The BP response was measured continuously at the history of cardiovascular disease, six patients had a middle finger of the non-dominant hand using a plethys-history of CHF. All patients were using cardiovascular mographic Finapres device (FINger Arterial PRESsure, medications during the study period. Patients were TNO-BMI, Academic Medical Centre, Amsterdam, The dialysed for 3.8±0.8 h for a target ultrafiltration of Netherlands). BP response was sampled at 100 Hz and stored 2.4±1.1 litres. Table 2 shows the changes in hydration digitally. All measurements were performed in triplicate. parameters during haemodialyis. Valsalva BP ratios UF, ultrafiltration; CHF, congestive heart failure; PAF, paroxysmal atrial fibrillation; MvI, mitral valve insufficiency; AoI, aortic valve insufficiency; IHD, ischaemic heart disease; MI, myocardial infarction; CM, cardiomyopathy; 1, cardiac glycoside; 2, diuretic; 3, ACE inhibitor; 4, beta-receptor blocker; 5, calcium-channel inhibitor; 6 nitrate; 7, alfa-receptor blocker. pre-or afterload reducing medication (all 5 patients). patients and the remaining 10 patients. Only measurement values obtained in the weeks before treatment of CHF in the five decompensated patients are included group. Average heart-chest-ratios on chest X-ray were equal for both groups (0.53) Three of the five patients in the analysis. Predialysis and postdialysis Valsalva BP ratios for the decompensated patients (0.89±0.05 experiencing acute CHF had a medical history of heart failure, two patients did not. and 0.78±0.05 respectively) were significantly higher than the predialysis and postdialysis values for the Table 4 gives sensitivity, specificity, and positive and negative predictive values for the predialysis Valsalva other 10 patients (0.77±0.10 and 0.70±0.11 respectively) (P<0.05). There were no significant differences BP ratio, elevated jugular venous pressure, and pulmonary rales, when used to identify patients at risk in the estimated blood volume changes, bioimpedance EFV estimations and clinical scores between the two for acute CHF. For the predialysis Valsalva BP ratios, a cut-off level of 0.82 resulted in a negative predictive groups, except for a higher predialysis oedema score and a higher postdialysis diastolic BP in the CHF value of 100% and a positive predictive value of 62%. All patients experiencing acute congestion and six of straining and may facilitate a rise in mean arterial pressure to control levels or above. The latter howthe 10 remaining patients had an elevated jugular venous pressure, resulting in a negative predictive value ever, does not always occur and is absent in Figure 1 . 3. A further drop in BP on release of strain. of 100% and a positive predictive value of 45%. Positive and negative predictive values for the presence of 4. A rebound overshoot in arterial pressure with a wide pulse pressure and bradycardia, due to the pulmonary rales were 40 and 70% respectively.
Comparison of clinical assessment and biorush of blood trapped in the venous bed into the heart, combined with reflex vasoconstriction and impedance parameters before and after treatment of the five patients who experienced an episode of CHF tachycardia. revealed that only the Valsalva BP ratios decreased
Hamilton et al. were the first to observe that in significantly from 0.89±0.05 to 0.75±0.07 (pre-patients with CHF the BP remains unchanged during dialysis) and from 0.78±0.05 to 0.70±0.02 (postdia-the straining phase of Valsalva's manoeuvre [5] . This lysis). The predialysis and postdialysis Valsalva BP results in a 'square-wave' appearance of the BP ratios after treatment did not differ from those found response ( Figure 2 ). This is explained by the increased for the patients without congestion. Other parameters central blood volume in patients with CHF. This acts did not change significantly after treatment of CHF.
as a reservoir, maintaining left ventricular filling despite a decrease in venous return during strain [16, 17] . As a result, BP remains elevated throughout the period of Discussion straining. The extent of BP decline during phase 2
In this small 5-week study of 15 patients on maintenance haemodialysis, five patients experienced an episode of acute heart failure with pulmonary congestion.
Comparison of these patients with the remaining 10 patients revealed a small, but significant difference in both predialysis and postdialysis BP response to Valsalva's manoeuvre. At a cut-off Valsalva BP ratio of 0.82, the positive predictive value for acute CHF was 62%, with a negative predictive value of 100%. Except for differences in diastolic BP and the presence of oedema, no other clinical signs or symptoms nor bioimpedance measurements were significantly different for the two patient groups. In addition, the Valsalva BP ratios appeared to normalize after treatment of CHF.
The normal BP response to a Valsalva's manoeuvre is divided into four phases (Figure 1 ):
1. An initial rise in systolic BP, which represents transmission of increased intrathoracic pressure to the periphery. 2. A drop to lower systolic and diastolic BP values and pulse pressure, caused by the decrease in venous return to the heart during strain. BP usually reaches tion. This prevents further BP decrease during appears to depend on the degree of central blood limits the usefulness of our test, since cardiac arrhythmia is common among patients on haemodiavolume increase, and predictable correlations between the phase 2 Valsalva BP response and invasive measure-lysis and patients with CHF. Autonomic dysfunction in haemodialysis patients often causes abnormal heart ment of left ventricular end-diastolic filling pressure have been demonstrated. McIntyre et al. measured the rate responses [19] , but initial effects on BP during the first seconds of strain are largely mechanical and BP response to Valsalva procedures non-invasively using a plethysmographic device. They reported a good independent of heart rate. Finally, no reference values for Valsalva BP ratios are available, and individual correlation of the BP response with the directly measured PCWP [12, 13] , as did others, who related systolic assessments can only be made in comparison to baseline measurements. BP ratio to PCWP [14] . The Valsalva procedure was also reported to be sensitive to treatment interventions Within the limits of this small study, we conclude that assessment of the Finapres BP response to a and safe in patient populations [12] .
We demonstrated a difference in Valsalva BP Valsalva's manoeuvre is a simple, safe, and noninvasive procedure, which appears to be a useful tool responses between haemodialysis patients about to experience acute CHF and patients not experiencing for identifying patients at risk of acute CHF during maintenance haemodialysis. such an event. Almost all other clinical parameters as well as bioelectrical impedance estimates of EFV did not differ between the two patients groups. Clinical Acknowledgements. experienced acute CHF had an elevated predialysis jugular venous pressure, this was also found for six of 10 patients who did not experience acute CHF. An
